Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -66,339 | -78,925 | N/A | N/A |
| Depreciation Amortization | 4,429 | 4,554 | N/A | N/A |
| Accounts receivable | -7,807 | 1,540 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,232 | 8,838 | N/A | N/A |
| Other Working Capital | -5,324 | 34,640 | N/A | N/A |
| Other Operating Activity | 33,517 | -14,103 | 0 | 0 |
| Operating Cash Flow | $-39,291 | $-43,455 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 49,457 | N/A | N/A | N/A |
| PPE Investments | -2,117 | -1,489 | N/A | N/A |
| Purchase Of Investment | -433,214 | -63,756 | N/A | N/A |
| Sale Of Investment | 177,127 | 237,623 | N/A | N/A |
| Purchase Sale Intangibles | -761 | -13,374 | N/A | N/A |
| Other Investing Activity | -600 | -135,155 | 0 | 0 |
| Investing Cash Flow | $-209,347 | $37,224 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,206 | 9,256 | N/A | N/A |
| Common Stock Issued | 228,658 | N/A | N/A | N/A |
| Other Financing Activity | -17,919 | -18 | 0 | 0 |
| Financing Cash Flow | $211,945 | $9,239 | $N/A | $N/A |
| Exchange Rate Effect | -70 | N/A | N/A | N/A |
| Beginning Cash Position | 90,452 | 83,562 | N/A | N/A |
| End Cash Position | 53,688 | 86,569 | N/A | N/A |
| Net Cash Flow | $-36,764 | $3,007 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -39,291 | -43,455 | N/A | N/A |
| Capital Expenditure | -2,150 | -1,489 | N/A | N/A |
| Free Cash Flow | -41,442 | -44,944 | 0 | 0 |